FLY-GEN is committed to improve the lives of elder patients suffering from wounds problems. The Company uses the natural biological compounds, fixed into the neutral matrix, modified enzymatic proteins focused on direct effect on non-viable tissues. They prevents effectively against antibiotic resistant bacteria, pathogenic fungi as well as regulate or eliminate the wound bed biofilm.
FLY-GEN is currently working on:
- Optimized enzymes selectively removing dead tissues from wounds
- Natural antimicrobial, antifungal and antitumor peptides combined with neutral and stable support for wounds treatment
- Own software for effective and robust drug design